Pfizer (PFE) Tops Q1 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.87 +0.30%
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $0.75, $0.03 better than the analyst estimate of $0.72. Revenue for the quarter came in at $14.5 billion versus the consensus estimate of $13.84 billion.
GUIDANCE:
Pfizer sees FY2026 EPS of $2.80-$3.00, versus the consensus of $2.96.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Ionic Digital backs Texas data center audit amid grid reliability push
- Kaiser Aluminum names Fred Stephan as CEO, effective November 2026
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
